The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models
Valentina Damato(University of Naples Federico II), Roberto Bianco(University of Naples Federico II)
Cited by 86
Related Papers
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
|Journal of Clinical Medicine|2020|105
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers
|British Journal of Cancer|2017|99
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells
|British Journal of Cancer|2014|58
Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status
|Oncotarget|2015|42
AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors
|Journal of Experimental & Clinical Cancer Research|2025|0